Long Acting Subcutaneous vs Short Acting Sublingual Buprenorphine in Pregnant and Lactating Women

NCT04212065 · clinicaltrials.gov ↗
PHASE4
Phase
WITHDRAWN
Status
OTHER
Sponsor class

Stopped closed due to new safety concerns of subcutaneous buprenorphine in pregnant patients

Conditions

Interventions

Sponsor

Ohio State University